Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía-Castro, Miguel
dc.contributor.authorFuentes-Ríos, David
dc.contributor.authorLópez-Romero, Juan Manuel 
dc.contributor.authorRomero, Antonio
dc.contributor.authorMoya-Utrera, Federico
dc.contributor.authorDíaz-Morilla, Amelia 
dc.contributor.authorSarabia-García, Francisco Ramón 
dc.date.accessioned2024-01-30T12:16:15Z
dc.date.available2024-01-30T12:16:15Z
dc.date.issued2023-12-13
dc.identifier.citationGarcía-Castro, M.; Fuentes-Rios, D.; López-Romero, J.M.; Romero, A.; Moya-Utrera, F.; Díaz-Morilla, A.; Sarabia, F. n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. Mar. Drugs 2023, 21, 637. https://doi.org/10.3390/md21120637es_ES
dc.identifier.urihttps://hdl.handle.net/10630/29402
dc.description.abstractA mathematical concept, n-tuples are originally applied to medicinal chemistry, especially with the creation of scaffold diversity inspired by the hybridisation of different commercial drugs with cytarabine, a synthetic arabinonucleoside derived from two marine natural products, spongouridine and spongothymidine. The new methodology explores the virtual chemical-factorial combination of different commercial drugs (immunosuppressant, antibiotic, antiemetic, anti-inflammatory, and anticancer) with the anticancer drug cytarabine. Real chemical combinations were designed and synthesised for 8-duples, obtaining a small representative library of interesting organic molecules to be biologically tested as proof of concept. The synthesised library contains classical molecular properties regarding the Lipinski rules and/or beyond rules of five (bRo5) and is represented by the covalent combination of the anticancer drug cytarabine with ibuprofen, flurbiprofen, folic acid, sulfasalazine, ciprofloxacin, bortezomib, and methotrexate. The insertion of specific nomenclature could be implemented into artificial intelligence algorithms in order to enhance the efficiency of drug-hunting programs. The novel methodology has proven useful for the straightforward synthesis of most of the theoretically proposed duples and, in principle, could be extended to any other central drug.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectQuímica farmacéuticaes_ES
dc.subject.othern-dupleses_ES
dc.subject.otherScaffold diversityes_ES
dc.subject.otherDual drugses_ES
dc.subject.otherChemical spacees_ES
dc.subject.otherArabinonucleosideses_ES
dc.titlen-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabinees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.3390/md21120637
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.departamentoQuímica Orgánica


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem